Evidence and findings
Fifty-two postmenopausal women were randomized to the two treatments for twelve weeks. The main measure was a vaginal maturation value, with a predefined increase used as the treatment-success criterion. [1]
Both groups improved from baseline. Estrogen had a higher success proportion at four weeks; a shared direction of improvement did not make the preparations equally effective. [1]
Interpretation and limits
The trial was small, used an active comparator and focused on a laboratory measure. It does not establish every symptom outcome or long-term safety. Funding and conflicts were not established from the abstract, and route-specific preparations cannot be replaced by products intended for another use. [1]
A hypothetical distinction
Imagine a study tests a manufactured suppository. Its results do not validate a different capsule’s ingredients or suitability for local use.
| Detail | Interpretation |
|---|---|
| Maturation value | Cellular outcome |
| Specified suppository | Tested preparation |
| Other product routes | Not interchangeable |
Sources for this article
- A survey of the therapeutic effects of Vitamin E suppositories on vaginal atrophy in postmenopausal women - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.